Quantum Pharma Share Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average Volume446,328 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive QP News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Pharma and its competitors with MarketBeat's FREE daily newsletter.

About Quantum Pharma

Quantum Pharma Plc is a pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesaler, hospital and homecare markets. The Company's core business is the manufacture, procurement and supply of unlicensed medicines (specials) and special obtains to the United Kingdom pharmacy chains. It operates through three segments: Specials; Niche Pharmaceuticals (Niche), and Medication Adherence (MA). The Specials segment engages in the manufacture, source and supply specials to pharmacies, pharmaceutical wholesalers, hospitals, and other specials suppliers throughout the United Kingdom and overseas. The Niche Pharmaceuticals segment develops and supplies nice pharmaceuticals, provides development and regulatory services, and out-licenses products and dossiers to third parties across Europe. The Medication Adherence segment provides products and services designed to provide adherence to medication regimes.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Quantum Pharma (LON:QP) Frequently Asked Questions

What stocks does MarketBeat like better than Quantum Pharma?

Wall Street analysts have given Quantum Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quantum Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Quantum Pharma's key executives?

Quantum Pharma's management team includes the following people:
  • Chris Rigg, Chief Executive Officer, Director
  • Gerard Thomas Murray, Chief Financial Officer, Director
  • George Liolios, Managing Director at Lamda
  • Brian Fisher, Joint Managing Director - Special Division
  • Nicola Massey, Managing Director - Niche Pharmaceuticals Division
  • Andrew Matthews, Joint Managing Director - Special Division
  • Ian Pearce, Managing Director - Medication Adherence Division
  • Craig Swinhoe, Group Legal and Projects Director and Company Secretary
  • Ian Roy Johnson, Non-Executive Chairman of the Board
  • Christopher Harwood Bernard Mills, Non-Executive Director

What other stocks do shareholders of Quantum Pharma own?

What is Quantum Pharma's stock symbol?

Quantum Pharma trades on the London Stock Exchange (LON) under the ticker symbol "QP."

How do I buy shares of Quantum Pharma?

Shares of QP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Quantum Pharma's official website?

The official website for Quantum Pharma is www.quantumpharmaceuticalgro....

Where are Quantum Pharma's headquarters?

How can I contact Quantum Pharma?

Quantum Pharma's mailing address is Quantum House Hobson Industrial Estate, Burnopfield, DURHAM, NE16 6EA, United Kingdom. The company can be reached via phone at +44-1207-279400.

This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.